Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial.
- Resource Type
- Article
- Authors
- Fuente, Macarena I de la; Colman, Howard; Rosenthal, Mark; Tine, Brian A Van; Levacic, Danijela; Walbert, Tobias; Gan, Hui K; Vieito, Maria; Milhem, Mohammed M; Lipford, Kathryn; Forsyth, Sanjeev; Guichard, Sylvie M; Mikhailov, Yelena; Sedkov, Alexander; Brevard, Julie; Kelly, Patrick F; Mohamed, Hesham; Monga, Varun
- Source
- Neuro-Oncology; Jan2023, Vol. 25 Issue 1, p146-156, 11p
- Subject
- Language
- ISSN
- 15228517